Komori
KYORIN Pharmaceutical (4569) · InitiativeFirst statedLatest Earnings presentation materials (2026-05-12): "Advanced"

Option Agreement with Biodol for a Drug Candidate to Treat Pain

First written in FY2025. 2 of 3 entries say "Advanced", first in 2026-03-31. Latest entry: 2026-05-12.

3entries
2years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-03-31 – 2026-05-122025: 120252026: 22026
Same theme, other companies
Option Agreement with Biodol for a Drug Candidate to Treat PainA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2025First statedAnnual report

    「In January 2025, we entered into an option agreement with Biodol for a drug candidate to treat pain.」

    An option agreement for a pain-treatment drug candidate was signed with Biodol in January 2025.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet. It last moved in the Earnings presentation materials of 2026-05-12: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Option Agreement with Biodol for a Drug Candidate to Treat Pain | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori